Letter to the editor regarding "The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis"

Saudi J Gastroenterol. 2022 Jan-Feb;28(1):81-82. doi: 10.4103/sjg.sjg_601_21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Calcineurin Inhibitors* / therapeutic use
  • Colitis, Ulcerative* / drug therapy
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Infliximab / therapeutic use
  • Steroids / therapeutic use

Substances

  • Calcineurin Inhibitors
  • Gastrointestinal Agents
  • Steroids
  • Infliximab